JP2025511086A5 - - Google Patents
Info
- Publication number
- JP2025511086A5 JP2025511086A5 JP2024557768A JP2024557768A JP2025511086A5 JP 2025511086 A5 JP2025511086 A5 JP 2025511086A5 JP 2024557768 A JP2024557768 A JP 2024557768A JP 2024557768 A JP2024557768 A JP 2024557768A JP 2025511086 A5 JP2025511086 A5 JP 2025511086A5
- Authority
- JP
- Japan
- Prior art keywords
- antigenic peptide
- amino acid
- acid sequence
- seq
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22305420.6 | 2022-03-31 | ||
| EP22305420 | 2022-03-31 | ||
| PCT/EP2023/058415 WO2023187127A1 (en) | 2022-03-31 | 2023-03-30 | Antigenic peptides for prevention and treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511086A JP2025511086A (ja) | 2025-04-15 |
| JP2025511086A5 true JP2025511086A5 (https=) | 2025-12-17 |
Family
ID=81325140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557768A Pending JP2025511086A (ja) | 2022-03-31 | 2023-03-30 | 癌の防止及び処置のための抗原性ペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250205324A1 (https=) |
| EP (1) | EP4499678A1 (https=) |
| JP (1) | JP2025511086A (https=) |
| CN (1) | CN119522232A (https=) |
| AU (1) | AU2023246941A1 (https=) |
| CA (1) | CA3246416A1 (https=) |
| MX (1) | MX2024011785A (https=) |
| WO (1) | WO2023187127A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120114579B (zh) * | 2025-04-27 | 2026-01-02 | 南京中医药大学 | 一种人参细胞工程化肿瘤疫苗及其制备方法与应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3841091A1 (de) | 1988-12-07 | 1990-06-13 | Behringwerke Ag | Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung |
| CA2006700A1 (en) | 1989-01-17 | 1990-07-17 | Antonello Pessi | Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| US5635363A (en) | 1995-02-28 | 1997-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
| GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
| ATE459373T1 (de) | 1999-03-19 | 2010-03-15 | Glaxosmithkline Biolog Sa | Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae |
| JP2002541808A (ja) | 1999-04-09 | 2002-12-10 | テクラブ， インコーポレイテッド | ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア |
| FR2798128B1 (fr) | 1999-09-06 | 2001-11-16 | Inst Nat Sante Rech Med | Moyens de detection et de purification de populations lymphocytaires t cd8+ specifiques de peptides presentes dans le contexte hla |
| AU7524601A (en) | 2000-06-05 | 2001-12-17 | Sunol Molecular Corp | T cell receptor fusions and conjugates and methods of use thereof |
| CA2501870C (en) | 2002-10-09 | 2013-07-02 | Avidex Limited | Single chain recombinant t cell receptors |
| PT1558643E (pt) | 2002-11-09 | 2009-08-24 | Immunocore Ltd | Apresentação de um receptor das células t |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| ES2532896T5 (es) | 2008-05-14 | 2018-03-20 | Immatics Biotechnologies Gmbh | Péptidos del MHC de clase II novedosos y potentes derivados de survivina y neurocan |
| EP2632955A1 (en) | 2010-10-26 | 2013-09-04 | Technion Research & Development Foundation Ltd. | Antibodies which bind soluble t-cell receptor ligands |
| DE19216461T1 (de) | 2011-10-03 | 2021-10-07 | Modernatx, Inc. | Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon |
| WO2013057586A1 (en) | 2011-10-19 | 2013-04-25 | Oslo Universitetssykehus Hf | Compositions and methods for producing soluble t - cell receptors |
| WO2013101690A1 (en) | 2011-12-29 | 2013-07-04 | modeRNA Therapeutics | Modified mrnas encoding cell-penetrating polypeptides |
| EP2639299A1 (en) | 2012-03-16 | 2013-09-18 | Invectys | Universal cancer peptides derived from telomerase |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| BR112017022845A2 (pt) * | 2015-04-23 | 2018-07-17 | Nantomics, Llc | neoepítopos de câncer |
| HRP20230007T1 (hr) * | 2018-04-11 | 2023-03-03 | Enterome S.A. | Antigenski peptidi, namijenjeni sprječavanju i liječenju raka |
-
2023
- 2023-03-30 AU AU2023246941A patent/AU2023246941A1/en active Pending
- 2023-03-30 CN CN202380040454.9A patent/CN119522232A/zh active Pending
- 2023-03-30 US US18/852,118 patent/US20250205324A1/en active Pending
- 2023-03-30 WO PCT/EP2023/058415 patent/WO2023187127A1/en not_active Ceased
- 2023-03-30 CA CA3246416A patent/CA3246416A1/en active Pending
- 2023-03-30 JP JP2024557768A patent/JP2025511086A/ja active Pending
- 2023-03-30 EP EP23717079.0A patent/EP4499678A1/en active Pending
-
2024
- 2024-09-25 MX MX2024011785A patent/MX2024011785A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8143211B2 (en) | Bioactive peptides | |
| CA2489227A1 (en) | Hla-a24-restricted cancer antigen peptides | |
| RU2355700C9 (ru) | Новые пептиды как ингибиторы ns3-серинпротеазы вируса гепатита с | |
| US5440016A (en) | Peptides of the formula (KFmoc) ZZZ and their uses | |
| JP2010500399A5 (https=) | ||
| IL262805B2 (en) | Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death | |
| JP2012500001A5 (https=) | ||
| CN102731629B (zh) | 一种抗菌肽及其应用 | |
| JP2011518179A5 (https=) | ||
| KR102852306B1 (ko) | 펩타이드 제조 공정 | |
| JP2008530975A5 (https=) | ||
| RU2013131089A (ru) | Пептиды тем8 и содержащие их вакцины | |
| RU2010111139A (ru) | Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства | |
| JP2023529839A5 (https=) | ||
| JP2025511086A5 (https=) | ||
| JP2025121987A (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| CN106188267B (zh) | 埃兹蛋白衍生肽及其药物组合物 | |
| JP7809117B2 (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| JP4902919B2 (ja) | ペプチド作成の方法 | |
| CN1316431A (zh) | 乙肝病毒抗原多肽与热休克蛋白的复合物及其应用 | |
| WO2017183559A1 (ja) | 薬物の経粘膜吸収促進剤 | |
| AU2020302077C1 (en) | Compositions and methods for treatment of fungal infections | |
| CN116157140A (zh) | 具有肾酶促效剂活性的稳定胜肽 | |
| CN101671390A (zh) | 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途 | |
| RU2024129346A (ru) | Антигенные пептиды для профилактики и лечения рака |